ABR INVESTOR UPDATE: Arbor Realty Trust, Inc. Investors that Lost Money are Notified to Contact BFA Law before September 30 Class Action Deadline (NYSE:ABR)
September 21, 2024 07:13 ET
|
Bleichmar Fonti & Auld
Arbor Realty Trust, Inc. investors that lost money on their investment are encouraged to contact BFA Law before September 30, 2024 legal deadline.
ME INVESTOR UPDATE: 23andMe Shareholders are Notified to Contact BFA Law about Ongoing Investigation into the Company for Breaches of Fiduciary Duties (Nasdaq:ME)
September 21, 2024 07:13 ET
|
Bleichmar Fonti & Auld
23andMe Holding Co. shareholders are encouraged to contact BFA Law about its investigation into the Board for breaches of fiduciary duties.
PacSun Goes Y2K This Fall! Get Ready for Low-Rise Jeans, Micro Minis & More
September 21, 2024 07:00 ET
|
PacSun
This season, PacSun is channeling denim and must-have styles with a collection that's both comfortable and cool.
Top Fall Must-Have Footwear Picks for Luxe Styles and Ultimate Comfort Under $50
September 21, 2024 07:00 ET
|
Dream Pairs
Dreams Pairs delivers style, comfort, and affordability without sacrificing quality! And they've got a few of the season's hottest trends.
Conquer Closet Chaos with Easy DIY Solutions from ClosetMaid
September 21, 2024 07:00 ET
|
ClosetMaid
ClosetMaid has organization solutions to upgrade your closet.
Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia
September 21, 2024 04:15 ET
|
Teva Pharmaceutical Industries Ltd
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in treating schizophrenia, including TEV-‘749Currently, there is no...
New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)
September 21, 2024 04:10 ET
|
Teva Pharmaceutical Industries Ltd
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific and clinical advances that support optimal treatment options and...
Ouverture de la troisième Conférence sur le développement du tourisme du Hunan à Hengyang, Hunan
September 21, 2024 04:01 ET
|
The 3rd Hunan Tourism Development Conference
HENGYANG, Chine, 21 sept. 2024 (GLOBE NEWSWIRE) -- La troisième Conférence sur le développement du tourisme du Hunan se tiendra dans la ville de Hengyang, dans la province du Hunan, dans le sud de...
ACADIA HEALTHCARE COMPANY, INC. ANNOUNCEMENT: If You Have Suffered Losses in Acadia Healthcare Company, Inc. (NASDAQ: ACHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
September 20, 2024 21:17 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Acadia...
ROSEN, A LEADING LAW FIRM, Encourages WEBTOON Entertainment Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBTN
September 20, 2024 21:07 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of WEBTOON Entertainment Inc. (NASDAQ: WBTN) pursuant and/or...
- September 20, 2024 20:05 ET AGEN Class Action Notice: Robbins LLP Reminds Agenus Inc. Stockholders of Pending AGEN Class Action Lawsuit
- September 20, 2024 16:01 ET Zefiro Methane Corp. Announces Appearances & Speaking Engagements at NYC Climate Week 2024